LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 49

Search options

  1. Article ; Online: Patients' understanding of treatment goals and disease course and their relationship with optimism, hope, and quality of life: a preliminary study among advanced breast cancer outpatients before receiving palliative treatment.

    Soylu, Cem / Babacan, Taner / Sever, Ali R / Altundag, Kadri

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

    2016  Volume 24, Issue 8, Page(s) 3481–3488

    Abstract: Purpose: The aims of this study were to explore advanced breast cancer patients' knowledge of treatment intent and expectation of illness course and to evaluate their relationship with optimism, hope, and quality of life (QoL).: Methods: Patients ... ...

    Abstract Purpose: The aims of this study were to explore advanced breast cancer patients' knowledge of treatment intent and expectation of illness course and to evaluate their relationship with optimism, hope, and quality of life (QoL).
    Methods: Patients with advanced breast cancer (n = 55) who were treated in the ambulatory clinic of the University of Hacettepe were included in the study. They completed Life Orientation Scale, The Hope Scale, and the European Organization for Research and Treatment of Cancer Quality of Life questionnaires. The data regarding the knowledge of illness progression and the perceptions of therapy intent were assessed using self-administered open-ended questionnaires that were answered by the patients.
    Results: The data revealed that 58.2 % of the patients had an inaccurate perception of treatment intent, believing the aim of treatment was cure, whereas only 38.2 % of the patients had a realistic expectation that their disease may remain stable or may progress over a year. In addition, the awareness of disease progression and perception of goals of treatment was significantly related to hope and optimism scores but not to QoL.
    Conclusions: A large proportion of patients diagnosed with advanced breast cancer believed that their treatment was "curative", and they would improve within a year. Findings of our study suggest that patients with inaccurate perception of treatment intent and unrealistic expectation of prognosis have higher hope and optimism scores than those who do not, but there were no significant differences in terms of global health status.
    MeSH term(s) Adult ; Aged ; Breast Neoplasms/mortality ; Breast Neoplasms/therapy ; Disease Progression ; Female ; Goals ; Hope ; Humans ; Middle Aged ; Optimism ; Outpatients ; Palliative Care/methods ; Prognosis ; Quality of Life/psychology ; Surveys and Questionnaires ; Young Adult
    Language English
    Publishing date 2016-08
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1134446-5
    ISSN 1433-7339 ; 0941-4355
    ISSN (online) 1433-7339
    ISSN 0941-4355
    DOI 10.1007/s00520-016-3182-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.

    Akin, Serkan / Babacan, Taner / Sarici, Furkan / Altundag, Kadri

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology

    2014  Volume 19, Issue 1, Page(s) 42–46

    Abstract: Breast cancer is the most common cancer in women worldwide. Understanding the biology of this tumor is a prerequisite for selecting an appropriate treatment. Cell cycle alterations are seen in many cancers such as breast cancer. Newly popular targeted ... ...

    Abstract Breast cancer is the most common cancer in women worldwide. Understanding the biology of this tumor is a prerequisite for selecting an appropriate treatment. Cell cycle alterations are seen in many cancers such as breast cancer. Newly popular targeted agent in breast cancer are cyclin dependent kinase inhibitors (CDKIs) which are agents inhibiting the function of cyclin dependent kinases (CDKs). They are categorized as selective and non-selective inhibitors of CDK. CDKIs have been tried as monotherapy and combination therapy. Palbocyclib is now a promising CDKI used in breast cancer. Nowadays palbocyclib is designed for a phase III trial for estrogen receptor (ER) positive breast cancer after showing favorable results in progression free survival in a phase II trial.
    MeSH term(s) Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Cycle/genetics ; Cyclin-Dependent Kinases/antagonists & inhibitors ; Cyclin-Dependent Kinases/metabolism ; Female ; Humans ; Molecular Targeted Therapy ; Protein Kinase Inhibitors/therapeutic use
    Chemical Substances Protein Kinase Inhibitors ; Cyclin-Dependent Kinases (EC 2.7.11.22)
    Language English
    Publishing date 2014-01
    Publishing country Greece
    Document type Journal Article ; Review
    ZDB-ID 2040386-0
    ISSN 2241-6293 ; 1107-0625
    ISSN (online) 2241-6293
    ISSN 1107-0625
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A case of vemurafenib-induced polyarhritis in a patient with melanoma: how to manage it?

    Babacan, Taner / Türkbeyler, Ibrahim Halil / Balakan, Ozan / Pehlivan, Yavuz / Suner, Ali / Kısacık, Bunyamin

    International journal of rheumatic diseases

    2017  Volume 20, Issue 3, Page(s) 398–401

    Abstract: Vemurafenib is an inhibitor of the BRAF V600E mutation which is associated with tumor responses in patients with metastatic melanoma. Although it is generally well tolerated, common side effects of vemurafenib have been reported. Arthralgia is one of the ...

    Abstract Vemurafenib is an inhibitor of the BRAF V600E mutation which is associated with tumor responses in patients with metastatic melanoma. Although it is generally well tolerated, common side effects of vemurafenib have been reported. Arthralgia is one of the more common adverse event associated with vemurafenib. We herein report a 49-year-old woman diagnosed with metastatic melanoma harboring the BRAF V600E mutation with severe polyarthritis associated with vemurafenib after 7 days of treatment. Sonographic examination of affected joints revealed synovitis and the patient's articular symptoms were improved by analgesic and anti-inflammatory treatment, including corticosteroids. During therapy with selective BRAF inhibitors, arthritis represents a new adverse event that can require dose reduction. In case of this adverse event, treatment with anti-inflammatory drugs, such as ibuprofen and prednisone, should be initiated early to keep patients on treatment and to avoid drug discontinuation and tumor progression.
    Language English
    Publishing date 2017-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2426924-4
    ISSN 1756-185X ; 1756-1841
    ISSN (online) 1756-185X
    ISSN 1756-1841
    DOI 10.1111/1756-185X.12396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Vismodegib in advanced basal-cell carcinoma.

    Babacan, Taner / Sarici, Furkan / Altundag, Kadri

    The New England journal of medicine

    2012  Volume 367, Issue 10, Page(s) 969–70; author reply 970

    MeSH term(s) Anilides/therapeutic use ; Antineoplastic Agents/therapeutic use ; Carcinoma, Basal Cell/drug therapy ; Female ; Hedgehog Proteins/antagonists & inhibitors ; Humans ; Male ; Pyridines/therapeutic use ; Skin Neoplasms/drug therapy
    Chemical Substances Anilides ; Antineoplastic Agents ; Hedgehog Proteins ; Pyridines
    Language English
    Publishing date 2012-09-06
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc1208003#SA1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Breast sarcoma: a rare malignancy.

    Gul, Gozde / Babacan, Taner / Akin, Serkan / Sarici, Furkan / Altundag, Kadri

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology

    2014  Volume 19, Issue 2, Page(s) 577

    MeSH term(s) Adult ; Aged ; Breast Neoplasms/therapy ; Female ; Humans ; Middle Aged ; Sarcoma/therapy
    Language English
    Publishing date 2014-04
    Publishing country Greece
    Document type Letter
    ZDB-ID 2040386-0
    ISSN 2241-6293 ; 1107-0625
    ISSN (online) 2241-6293
    ISSN 1107-0625
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Leg cramps associated with tamoxifen use--possible mechanism and treatment recommendations.

    Karatas, Fatih / Sahin, Suleyman / Babacan, Taner / Akin, Serkan / Sever, Ali R / Altundag, Kadri

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology

    2016  Volume 21, Issue 2, Page(s) 520

    MeSH term(s) Antineoplastic Agents, Hormonal/adverse effects ; Breast Neoplasms/drug therapy ; Female ; Humans ; Lower Extremity/blood supply ; Muscle Cramp/chemically induced ; Muscle Cramp/diagnosis ; Muscle Cramp/metabolism ; Muscle Cramp/physiopathology ; Nitric Oxide/metabolism ; Posture ; Regional Blood Flow ; Tamoxifen/adverse effects ; Vasodilation
    Chemical Substances Antineoplastic Agents, Hormonal ; Tamoxifen (094ZI81Y45) ; Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 2016-03
    Publishing country Greece
    Document type Letter
    ZDB-ID 2040386-0
    ISSN 2241-6293 ; 1107-0625
    ISSN (online) 2241-6293
    ISSN 1107-0625
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A patient with pneumopericardium secondary to extranodal T-cell lymphoma.

    Sener, Yusuf Ziya / Babacan, Taner / Sarica, Mehmet Akif / Turkbeyler, Ibrahim Halil

    BMJ case reports

    2013  Volume 2013

    Abstract: Natural killer (NK)/T-cell lymphomas represent a rare type of lymphoma derived from either activated NK cells or cytotoxic T cells. Most cases with T/NK cell lymphoma present with extranodal manifestations. Primary nodal disease is very rare. The upper ... ...

    Abstract Natural killer (NK)/T-cell lymphomas represent a rare type of lymphoma derived from either activated NK cells or cytotoxic T cells. Most cases with T/NK cell lymphoma present with extranodal manifestations. Primary nodal disease is very rare. The upper respiratory tract is the most common site involved in extranodal disease. Symptoms include epistaxis and nasal obstruction. T/NK cell lymphomas show aggressive and invasive clinical progression, with a poor prognosis. Without treatment, survival is measured in months. We report a case of a 51-year-old male patient with pneumopericardium as a complication of intestinal T/NK cell lymphoma. To the best of our knowledge, this is the first report showing pneumopericardium as a fatal complication of T/NK cell lymphoma. Pneumopericardium should be considered in patients diagnosed with T/NK cell lymphoma presenting with chest pain.
    MeSH term(s) Chest Pain/etiology ; Diagnosis, Differential ; Humans ; Lymphoma, T-Cell/complications ; Male ; Middle Aged ; Pneumopericardium/diagnosis ; Pneumopericardium/diagnostic imaging ; Pneumopericardium/etiology ; Tomography, X-Ray Computed
    Language English
    Publishing date 2013-11-12
    Publishing country England
    Document type Case Reports ; Journal Article
    ISSN 1757-790X
    ISSN (online) 1757-790X
    DOI 10.1136/bcr-2013-201742
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: How long should we maintain anti-HER2 therapy for metastatic breast cancer patients with complete remission?

    Hacioglu, Bekir / Akin, Serkan / Babacan, Taner / Sever, Ali R / Altundag, Kadri

    Future oncology (London, England)

    2015  Volume 11, Issue 20, Page(s) 2799–2801

    MeSH term(s) Antineoplastic Agents/administration & dosage ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Female ; Humans ; Receptor, ErbB-2/genetics ; Trastuzumab/administration & dosage
    Chemical Substances Antineoplastic Agents ; Receptor, ErbB-2 (EC 2.7.10.1) ; Trastuzumab (P188ANX8CK)
    Language English
    Publishing date 2015
    Publishing country England
    Document type Editorial
    ZDB-ID 2184533-5
    ISSN 1744-8301 ; 1479-6694
    ISSN (online) 1744-8301
    ISSN 1479-6694
    DOI 10.2217/fon.15.165
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Can aromatase inhibitors cause forgetfulness in women with breast cancer ?

    Karatas, Fatih / Akin, Serkan / Babacan, Taner / Sever, Ali R / Altundag, Kadri

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology

    2015  Volume 20, Issue 3, Page(s) 935

    MeSH term(s) Antineoplastic Agents, Hormonal/adverse effects ; Aromatase Inhibitors/adverse effects ; Breast Neoplasms/drug therapy ; Female ; Humans ; Memory/drug effects ; Memory Disorders/chemically induced ; Memory Disorders/diagnosis ; Memory Disorders/psychology ; Risk Assessment ; Risk Factors
    Chemical Substances Antineoplastic Agents, Hormonal ; Aromatase Inhibitors
    Language English
    Publishing date 2015-05
    Publishing country Greece
    Document type Letter
    ZDB-ID 2040386-0
    ISSN 2241-6293 ; 1107-0625
    ISSN (online) 2241-6293
    ISSN 1107-0625
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Insomnia caused by aromatase inhibitors; a therapeutic challenge in patients with breast cancer.

    Karatas, Fatih / Sahin, Suleyman / Babacan, Taner / Akin, Serkan / Sever, Ali R / Altundag, Kadri

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology

    2015  Volume 20, Issue 6, Page(s) 1640

    MeSH term(s) Aromatase Inhibitors/adverse effects ; Breast Neoplasms/drug therapy ; Female ; Humans ; Sleep Initiation and Maintenance Disorders/chemically induced
    Chemical Substances Aromatase Inhibitors
    Language English
    Publishing date 2015-11
    Publishing country Greece
    Document type Letter
    ZDB-ID 2040386-0
    ISSN 2241-6293 ; 1107-0625
    ISSN (online) 2241-6293
    ISSN 1107-0625
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top